This site is intended for healthcare professionals
Login | Register (NOW FREE)

Medical search


FREE subscriptions for doctors and students... click here
You have 3 open access pages.

This is a drug used in the treatment of cardiac failure and hypertension.

Mode of action:

  • direct relaxing effect on vascular smooth muscle resulting in peripheral arteriolar dilatation

There is a fall in blood pressure and consequent reflex tachycardia as a result of the peripheral arteriolar dilatation caused by hydralazine. Thus, in the treatment of hypertension, a beta-adrenoreceptor blocker is also is used. There is little reflex tachycardia when this drug is used to treat cardiac failure because there is no significant change in blood pressure.


  • t 1/2 - approximately 4 hours
  • metabolised - mainly by acetylation

Side effects:

  • palpitations, nausea, vomiting, tachycardia, postural hypotension
  • with dosages over 200 mg then there may be the development of a lupus-like syndrome or an arthropathy resembling rheumatoid arthritis. The lupus-like syndrome that may occur with the use of hydralazine is more commonly seen in patients with HLA DR4.


The information provided herein should not be used for diagnosis or treatment of any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Copyright 2016 Oxbridge Solutions LtdĀ®. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions LtdĀ® receives funding from advertising but maintains editorial independence. GPnotebook stores small data files on your computer called cookies so that we can recognise you and provide you with the best service. If you do not want to receive cookies please do not use GPnotebook.